Company: PMVP
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001140361-25-015610
Chunk: 44

Company: PMV Pharmaceuticals, Inc.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 44
---
 of Outstanding and Unvested Equity Awards Granted in the Year |     |    757,593 |     |    520,378 |     |    881,664 |
| Change in Fair Value of Existing Unvested Equity Awards(2)                        |     |    308,858 |     |   -714,199 |     | -1,907,525 |
| Change in Fair Value of Vested Equity Awards                                      |     |     -5,425 |     |   -330,487 |     |   -658,894 |
| Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year     |     |    161,999 |     |    156,876 |     |    403,479 |
| Compensation Actually Paid to PEO                                                 |     | $2,166,091 |     |   $513,651 |     | $(519,251) |

| (1) | Represents the grant fair value of the equity awards to our PEO, as reported in the SCT. |

| (2) | In August 2024, in connection with the Company offering of a one-time voluntary stock option exchange to its employees, stock options held by our CEO and Non-CEO NEOs were exchanged for new stock options with an exercise price equal to $1.48per share and a new vesting schedule (“Option Exchange”), with all other terms remaining the same. As there had beennoexercises of any of the previous stock options as of the date of the Option Exchange, both vested and unvested options were exchanged1-for-1for the new unvested stock options which had a vesting commencement date in September 2024. For purposes of calculating compensation actually paid, shown in the table above, the incremental change in fair value recognized related to the Option Exchange is reflected in this row. |

25

TABLE OF CONTENTS

| NEOs SCT Total to CAP Reconciliation                                              |     |       2024 |     |       2023 |     |       2022 |
| SCT Total Compensation                                                            |     | $1,654,265 |     | $1,178,729 |     | $2,129,278 |
| SCT Option Awards(1)                                                              |     | -1,068,682 |     |   -553,630 |     | -1,177,183 |
| Year End Fair Value of Outstanding and Unvested Equity Awards Granted in the Year |